SEARCH

SEARCH BY CITATION

References

  • 1
    . Felson DT, Anderson JJ, Meenan RF: Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials. Arthritis Rheum 33: 140149, 1990
  • 2
    . Ward JR, Williams HJ, Egger MJ, Reading JC, Boyce E, Altz-Smith M, Samuelson CO Jr, Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M, Kaplan SB, Klippel J: Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 26: 13031315, 1983
  • 3
    . Makuch R, Simon R: Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep 62: 10371040, 1978
  • 4
    . Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC: Meta-analysis of randomized controlled trials. N Engl J Med 316: 450455, 1987
  • 5
    . Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 6
    . Anderson JJ, Felson DT, Meenan RF, Williams HJ: Which? traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum 32: 10931099, 1989
  • 7
    . Eberl DR, Fasching V, Rahlfs V, Schleyer I, Wolf R: Repeatability and objectivity of various measurements in rheumatoid arthritis. Arthritis Rheum 19: 12781286, 1976
  • 8
    . Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos T, Grieveson P, Buchanan W: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393406, 1968
  • 9
    . DerSimonian R, Charette LJ, McPeek B, Mosteller F: Reporting on methods in clinical trials. N Engl J Med 306: 13321337, 1982
  • 10
    . Anscombe FJ: The transformation of Poisson, binomial, and negative-binomial data. Biometrika 5: 246254, 1958
  • 11
    . DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials 7: 177188, 1986
  • 12
    . Meenan RF, Anderson JJ, Lewis LE, Egger MJ, Altz-Smith M, Samuelson CO Jr, Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Guttadauria M, Kaplan SB, Klippel J: Outcome assessment in clinical trials: evidence for the sensitivity of a health status measure. Arthritis Rheum 27: 13441352, 1984
  • 13
    . Smith PR, Brown GMM, Meyers OL: An open comparative study of auranofin vs. gold sodium thiomalate. J Rheumatol [Suppl] 9: 190196, 1982
  • 14
    . Horton RJ: Comparative safety and efficacy of auranofin and parenteral gold compounds: a review. Scand J Rheumatol [Suppl] 51: 100110, 1983
  • 15
    . Mackenzie AH: Antimalarial drugs for rheumatoid arthritis. Am J Med 75 (suppl 6A): 4858, 1983
  • 16
    . Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818822, 1985
  • 17
    . Anderson PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL: Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 103: 489496, 1985
  • 18
    . Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS: A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol 15: 753756, 1988
  • 19
    . Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I: Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16: 313320, 1989
  • 20
    . Morassut P, Goldstein R, Cyr M, Karsh J, McKendry RJR: Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized double blind 26-week trial. J Rheumatol 16: 302306, 1989
  • 21
    . Hamdy H, McKendry RJR, Mierins E, Liver JA: Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a twenty-four-week controlled clinical trial. Arthritis Rheum 30: 361368, 1987
  • 22
    . Williams HJ, Willkens RF, Samuelson CO Jr, Alarcon GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721730, 1985
  • 23
    . Schattenkirchner M, Missler B, Mulz D: Postmarketing experience with auranofin in the Federal Republic of Germany. Scand J Rheumatol [Suppl] 51: 5766, 1983
  • 24
    . Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF, Oglesby T, Weisman MH, Schlegel S, Michaels RM, Luggen ME, Polisson RP, Singer JZ, Kantor SM, Shiroky JB, Small RE, Gomez MI, Reading JC, Egger MJ: A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 31: 702713, 1988
  • 25
    . Nuver-Zwart IH, Van Riel PLCM, Van de Putte LB, Gribnau FWJ: A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis 48: 389395, 1989
  • 26
    . Neumann VC, Grindulis KA, Huball S, McConkey B, Wright V: Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. Br Med J 287: 10991102, 1983
  • 27
    . Taggart AJ, Hill J, Astbury C, Dixon JS, Bird HA, Wright V: Sulphasalazine alone or in combination with d-penicillamine in rheumatoid arthritis. Br J Rheumatol 26: 3236, 1987
  • 28
    . Pullar T, Hunter JA, Capell HA: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol 24: 269278, 1985
  • 29
    . Pullar T, Hunter JA, Capell HA: Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 287: 11021104, 1983
  • 30
    . Pinals RS, Kaplan SB, Lawson JG, Hepburn B: Sulfasalazine in rheumatoid arthritis: a double-blind, placebo-controlled trial. Arthritis Rheum 29: 14271434, 1986
  • 31
    . Skoskey JL: Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis. J Rheumatol [Suppl] 15: 58, 1988
  • 32
    . Hill HFH: Treatment of rheumatoid arthritis with penicillamine. Semin Arthritis Rheum 6: 361388, 1977
  • 33
    . Jaffe IA: The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum 13: 436443, 1970
  • 34
    . Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB: A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 31: 121130, 1990
  • 1
    . Anderson PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL: Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 103: 489496, 1985 ( E,T)
  • 2
    . Baldassare AR, Weiss TD, Arthur E, Osborn TG, Moore TL, Zuckner J: Auranofin in the treatment of rheumatoid arthritis: a two-year study. Mo Med 82: 711715, 1985 (E, T)
  • 3
    . Barraclough D. Boyden K, Brooks P, Thomas D, Brook A, Tymms K: A comparative study of auranofin, gold sodium thiomalate and d-penicillamine in rheumatoid arthritis: a progress report, Auranofin: Proceedings of a Smith, Kline & French Internationa. Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E, T)
  • 4
    . Bernhard GC: Auranofin treatment for adult rheumatoid arthritis: comparison of 2 mg and 6 mg daily dose. J Rheumatol [Suppl] 9: 149153, 1982 (E, T)
  • 5
    . Berry H, Liyanage SP, Durance RA, Barnes CG, Berger LA, Evans S: Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. Br Med J 1: 10521054, 1976 (E, T)
  • 6
    . Bird HA, Gallez PL, Dixon JS, Surrall KE, Cole DS, Goldman MH, Wright V: A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis. Clin Rheumatol 3 (suppl 1): 5766, 1984 (E, T)
  • 7
    . Bombardier CL, Wares J, Russell IJ, Larson M, Chalmers A, Read JL: Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of multicenter trial. Am J Med 81: 565578, 1986 (E, T)
  • 8
    . Capell HA, Hunter JA, Rennie AN, Murdoch RN: Levamisole: a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis? J? Rheumatol 8: 730740, 1981 (E, T)
  • 9
    The Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 16: 353358, 1973 (E, T)
  • 10
    . Currey HLF, Harris J, Mason RM, Woodland J, Beveridge T, Roberts CJ, Vere DW, Dixon ASJ, Davies J, Owen-Smith B: Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J 3: 763766, 1974 (E, T)
  • 11
    . Davies J, Bacon PA, Hall ND, Ring EFJ: Placebo-controlled comparison of auranofin with myocrisin in patients with rheumatoid arthritis, Auranofin: Proceedings of a Smith, Kline & French Internationa. Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E, T)
  • 12
    . Davis P, Menard H, Thompson J, Harth M, Beaudet F: One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. J Rheumatol 12: 6067, 1985 (E, T)
  • 13
    . Dequeker J, Francx L, Deckers Y: Comparison of oral gold (auranofin) and injectable gold (allochrysine, gold sodium thiopropanolsulphate) treatment in patients with rheumatoid arthritis: a single-blind study, Auranofin: Proceedings of a Smith, Kline & French Internationa. Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E, T)
  • 14
    . Dixon ASJ, Davies J, Dormandy TL, Hamilton EBD, Holt PJL, Mason RM, Thompson M, Weber JCP, Zutshi DW: Synthetic D(-) penicillamine in rheumatoid arthritis: double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis 34: 416421, 1975 (E, T)
  • 15
    . Dwosh IL, Stein HB, Urowitz MB, Smythe HA, Hunter T, Ogryzlo MA: Azathioprine in early rheumatoid arthritis: comparison with gold and chloroquine. Arthritis Rheum 20: 685692, 1977 (E, T)
  • 16
    . El-Ghobarey AF, Mavrikakis ME, Macleod M, Reynolds PMG, Capell HA, Spencer DG, Balint G, Mathieu JP, McAllister T, Cooney A, Dick WC: Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med 47: 385400, 1978 (E, T)
  • 17
    . Felix-Davies D, Stewart A, Wilkinson BR, Bateman JR, Delamere JP: A 12-month comparative trial of auranofin and d-penicillamine in rheumatoid arthritis. Am J Med 75: 138141, 1983 (E, T)
  • 18
    . Finkelstein AE, Roisman FR, Batista V, De Nudelman FG, De Titto EM, Mizraji M, Walz DT: Oral chrysotherapy in rheumatoid arthritis: minimum effective dose. J Rheumatol 7: 160168, 1980 (E, T)
  • 19
    . Fowler PD, Shadforth MF, Crook PR, Lawton A: Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study. Ann Rheum Dis 43: 200204, 1984 (E, T)
  • 20
    . Freedman A: Chloroquine and rheumatoid arthritis: a short-term controlled trial. Ann Rheum Dis 15: 251257, 1956 (T)
  • 21
    . Freedman A, Steinberg VL: Chloroquine in rheumatoid arthritis: a double-blind trial of treatment for one year. Ann Rheum Dis 19: 243250, 1960 (E, T)
  • 22
    . Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I: Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16: 313320, 1989 (E, T)
  • 23
    . Furst DE, Levine S, Srinivasan R, Metzger AL, Bangert R, Paulus HE: A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis. Arthritis Rheum 20: 14731480, 1977 (E, T)
  • 24
    . Gibson T, Emery P, Armstrong RD, Crisp AJ, Panayi GS: Combined d-penicillamine and chloroquine treatment of rheumatoid arthritis: a comparative study. Br J Rheumatol 26: 279284, 1987 (E, T)
  • 25
    . Halberg P, Bentzon M, Crohn O, Gad I, Halskov O, Heyn J, Ingemann N, Junker P, Lorenzen I, Moller I, Hansen TM, Olsen N, Pedersen G, Sorensen SF, Stage P: Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Dan Med Bull 31: 403409, 1984 (E, T)
  • 26
    . Hamdy H, McKendry RJR, Mierins E, Liver JA: Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a twenty-four-week controlled clinical trial. Arthritis Rheum 30: 361368, 1987 (E, T)
  • 27
    . Hamilton EBD, Scott JT: Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis. Arthritis Rheum 5: 502512, 1962 (E, T)
  • 28
    . Hill HFH, Hill AGS, Day AT, Brown RM, Golding JR, Lyle WH: Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen. Ann Rheum Dis 38: 429433, 1979 (E, T)
  • 29
    . Hochberg MC: Auranofin or d-penicillamine in the treatment of rheumatoid arthritis. Ann Intern Med 105: 528535, 1986 (E, T)
  • 30
    . Huskisson EC, Gibson TJ, Balme HW, Berry H, Burry HC: Trial comparing D-penicillamine and gold in rheumatoid arthritis. Ann Rheum Dis 33: 532535, 1974 (E, T)
  • 31
    . Huskisson EC, Scott J, Balme HW, Dieppe PA, Trapnell J, Willoughby DA: Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet 1: 393395, 1976 (E, T)
  • 32
    . Jarner D, Ammitzboll F, Sinding J, Menck Thygesen H: Auranofi. and myocrisin (gold sodium thiomalate): a double-blind comparative study, Auranofin: Proceedings of a Smith, Kline & French International Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E, T)
  • 33
    . Kadir N, Grayson MF, Campbell ED: A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis. Ann Clin Res 15: 49, 1983 (E, T)
  • 34
    . Kahn MF, Doury P, Delcambre B, Desproges-Botteron R, Gougeon J, Kuntz D, D'Eshougues JR, Roux H, Sany J: A multicentre double-blind comparative study of auranofin and intramuscular gold (allochrysine), Auranofin: Proceedings of a Smith, Kline & French Internationa. Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E, T)
  • 35
    . Kaik B, Broll H, Muller-Fassbender H, Rau R, Schattenkirchner M, Zeidler H: Auranofi. and tauredon in the treatment of chronic polyarthritis, Auranofin: Proceedings of a Smith, Kline & French International Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E)
  • 36
    . Katz WA, Alexander S, Bland JH, Blechman W, Bluhm GB, Bonebrake RA, Falbo A, Greenwald RA, Hartman S, Hobbs T, Indenbaum S, Lergier JE, Lanier BG, Lightfoot RW Jr, Phelps P, Sheon RP, Torretti D, Wenger ME, Wilske K: The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. J Rheumatol [Suppl] 9: 173178, 1982 (T)
  • 37
    . Keegan DAJ, Cole DS, Hodkinson E, Podmore P: A comparative open study of the efficacy and safety of gold sodium thiomalate and auranofin treatment in patients with rheumatoid arthritis, Auranofin: Proceedings of a Smith, Kline & French Internationa. Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E, T)
  • 38
    . Lewis D, Capell HA: Is? auranofin preferable to gold sodium thiomalate in the management of rheumatoid arthritis? Curr Clin Prac 7: 147155, 1987 (T)
  • 39
    . Lund B, Graae A, Sonne I, Andersen RB: Longterm treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters. Eur J Rheumatol Inflamm 6: 279287, 1983 (E, T)
  • 40
    . Mainland D, Sutcliffe MI: Hydroxychloroquine sulfate in rheumatoid arthritis, a six month, double-blind trial. Bull Rheum Dis 13: 287290, 1962 (E, T)
  • 41
    . Makisara P, Nissila M, Kajander A, Martio JL: Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Scand J Rheumatol 7: 166170, 1978 (E, T)
  • 42
    . Manthorpe R, Horbov S, Sylvest J, Vinterberg H: Auranofin versus penicillamine in rheumatoid arthritis: one-year results from a prospective clinical investigation. Scand J Rheumatol 15: 1322, 1986 (E, T)
  • 43
    . Mery C, Delrieu F, Ghozlan R, Saporta L, Simon F, Amor B, Menkes CJ, Delbarre R: Controlled trial of D-penicillamine in rheumatoid arthritis: dose effect and the role of zinc. Scand J Rheumatol 5: 241247, 1976 (E, T)
  • 44
    . Morassut P, Goldstein R, Cyr M, Karsh J, McKendry RJR: Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26-week trial. J Rheumatol 16: 302306, 1989 (E, T)
  • 45
    . The Multicentre Trial Group: Controlled trial of D(-) penicillamine in severe rheumatoid arthritis. Lancet I: 275280, 1973 (E, T)
  • 46
    . Neumann VC, Grindulis KA, Huball S, McConkey B, Wright V: Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. Br Med J 287: 10991102, 1983 (E, T)
  • 47
    . Nuver-Zwart IH, Van Riel PLCM, Van de Putte LBA, Gribnau FWJ: A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis 48: 389395, 1989 (E, T)
  • 48
    . Paulus HE, Williams HJ, Ward JR, Reading JC, Egger MJ, Coleman ML, Samuelson CO Jr, Willkens RF, Guttadauria M, Alarcón GS, Kaplan SB, MacLaughlin EJ, Weinstein A, Wilder RL, Solsky MA, Meenan RF: Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold. Arthritis Rheum 27: 721727, 1984 (E, T)
  • 49
    . Pavelka K, Sen KP, Peliskova Z, Vacha J, Trnavsky K: Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens. Ann Rheum Dis 48: 542546, 1989 (E, T)
  • 50
    . Pinals RS, Kaplan SB, Lawson JG, Hepburn B: Sulfasalazine in rheumatoid arthritis: a double-blind, placebo-controlled trial. Arthritis Rheum 29: 14271434, 1986 (E, T)
  • 51
    . Popert AJ, Meijers KAE, Sharp J, Bier F: Chloroquine diphosphate in rheumatoid arthritis: a controlled trial. Ann Rheum Dis 20: 1833, 1961 (E, T)
  • 52
    . Pullar T, Hunter JA, Capell HA: Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 287: 11021104, 1983 (T)
  • 53
    . Pullar T, Hunter JA, Capell HA: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol 24: 269276, 1985 (E, T)
  • 54
    . Raeman F, Hanssens F, Delattre M: An European open multi-centre trial with auranofin in rheumatoid arthritis. Clin Rheumatol 3 (suppl 1): 3338, 1984 (E, T)
  • 55
    . Rau R, Schattenkircher M, Muller-Fassbender H, Kaik B, Zeidler H: A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA). Clin Rheumatol 6 (suppl 2): 4352, 1987 (E, T)
  • 56
    . Research Sub-Committee of the Empire Rheumatism Council: Gold therapy in rheumatoid arthritis: report of a multi-centre controlled trial. Ann Rheum Dis 19: 95119, 1960 (E, T)
  • 57
    . Richards IM, Fraser SM, Hunter JA, Capell HA: Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis. Ann Rheum Dis 46: 667669, 1987 (E, T)
  • 58
    . Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H: Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis: a double-blind, comparative multi-center study. J Rheumatol [Suppl] 9: 184189, 1982 (T)
  • 59
    . Scott DL, Dawes PT, Tunn E, Fowler PD, Shadforth MF, Fisher J, Clarke S, Collins M, Jones P, Popert AJ, Bacon PA: Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized placebo-controlled study. Br J Rheumatol 28: 128133, 1989 (E, T)
  • 60
    . Shiokowa Y, Horiuchi Y, Honma M, Kageyama T, Okada T, Azuma T: Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum 20: 14641472, 1977 (T)
  • 61
    . Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR: Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Ann Intern Med 80: 2126, 1974 (E, T)
  • 62
    . Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS: A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol 15: 753756, 1988 (E, T)
  • 63
    . Taggart AJ, Hill J, Astbury C, Dixon JS, Bird HA, Wright V: Sulphasalazine alone or in combination with d-penicillamine in rheumatoid arthritis. Br J Rheumatol 26: 3236, 1987 (E, T)
  • 64
    . Tvede N, Strandberg B: Th. effect of auranofin compared with myocrisin in the treatment of rheumatoid arthritis, Auranofin: Proceedings of a Smith, Kline & French International Symposium, Amsterdam, 1982. New York, Excerpta Medica, 1982 (E)
  • 65
    . Van Riel PLCM, Larsen A, Van de Putte LBA, Gribnau FW: Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Clin Rheumatol 5: 359364, 1986 (T)
  • 66
    . Vischer TL: A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis. Ann Rheum Dis 47: 582587, 1988 (E, T)
  • 67
    . Walravens M, Dequeker J: Comparison of gold and orgotein treatment in rheumatoid arthritis. Curr Ther Res 20: 6269, 1976 (E, T)
  • 68
    . Ward JR, Williams HR, Egger MJ, Reading JC, Boyce E, Altz-Smith M, Samuelson CO Jr, Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M, Kaplan SB, Klippel J: Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 26: 13031315, 1983 (E, T)
  • 69
    . Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DR, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818822, 1985 (E, T)
  • 70
    . Wenger ME, Alexander S, Bland JH, Blechman WJ: Auranofin versus placebo in the treatment of rheumatoid arthritis. Am J Med 75 (suppl 6A): 123127, 1983 (E, T)
  • 71
    . Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF, Oglesby T, Weisman MH, Schlegel S, Michaels RM, Luggen ME, Polisson RP, Singer JZ, Kantor SM, Shiroky JB, Small RE, Gomez MI, Reading JC, Egger MJ: A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 31: 702713, 1988 (E, T)
  • 72
    . Williams HJ, Ward JR, Reading JC, Egger MJ, Grandone JT, Samuelson CO, Furst DE, Sullivan JM, Watson MA, Guttadauria M, Cathcart ES, Kaplan SB, Halla JT, Weinstein A, Plotz P: Low-dose D-penicillamine therapy in rheumatoid arthritis: a controlled, double-blind clinical trial. Arthritis Rheum 26: 581592, 1983 (E, T)
  • 73
    . Williams HJ, Willkens RF, Samuelson CO Jr, Alarcón GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721730, 1985 (E, T)